From general hospital to oncology specialist
For international patients who are considering being evaluated for hematological tumors in Shanghai, when understanding a hospital, they should also look at the specialist team, specific treatment directions, and support system during the diagnosis and treatment process. This topic is based on Jiahui’s official information and public cases, focusing on CAR-T related information.
Overview of Shanghai Jiahui International Hospital
Jiahui International Hospital was put into operation in Xuhui District, Shanghai in 2017, with an approved bed capacity of 500. According to the official website of the hospital, it has more than 35 departments, with special centers such as oncology, women and children, orthopedics and sports health management, and cardiology, and provides 24-hour emergency services.
CAR-T: cell-based therapy
CAR-T is a type of cellular immunotherapy that changes T cells so that they can recognize specific tumor targets. Treatment requires the connection of cell collection, preparation, reinfusion and subsequent monitoring. The scope of application depends on the product and patient conditions.
Reading highlights
specialist assessmentClarify disease classification and treatment goals
Professional teamLearn about blood cancer and cell therapy experience
Treatment interfacePay attention to collection, preparation, reinfusion and follow-up
International medical treatmentConfirm language, medical records, appointments and stay arrangements
Jiahui’s cancer diagnosis and treatment system
Cancer Center and Hematology Specialty
The public services of Jiahui International Cancer Center include diagnosis, surgery, radiotherapy and chemotherapy, targeted and immunotherapy, CAR-T and anti-cancer support services. Hematology specializes in malignant blood diseases such as lymphoma, myeloma, and leukemia, and also diagnoses and treats some benign blood diseases. The scope of oncology services provided by the hospital is broader than the CAR-T that this article focuses on.
Jiahui Cancer Center Services ↗Jiahui·Hematology ↗How does multidisciplinary collaboration participate in diagnosis and treatment?
For patients with complex conditions or who have received multiple lines of treatment in the past, the focus is not only on a certain technology, but also on how different specialties can jointly evaluate it. Patients can ask during the first consultation whether pathological review, imaging discussion, or other specialist consultations are needed, and who will put together the final plan.
Cooperation background with Massachusetts General Hospital in the United States
According to the official website of Jiahui International Cancer Center, it is a strategic cooperative medical center in China between the Massachusetts General Hospital and Cancer Center in the United States. This is part of understanding the professional background of the hospital. If there is a need for overseas expert consultation, the participation method and the content of this service should be verified separately.
Jiahui International Cancer Center · Official Introduction ↗Before coming to Shanghai, confirm the specific services with the hospital
| Pay attention to the link | Suggested questions to confirm | desired results |
|---|---|---|
| initial assessment | Which department does the treatment come from? Is the information complete? | Admission directions and supplementary materials list |
| treatment discussion | Is a multidisciplinary opinion required? What are the options? | Treatment paths and risks explained by the hospital |
| Hospital connection | How to arrange collection and return? | Stage time and hospitalization arrangements |
| Discharge follow-up | Who is responsible for review and contact after returning to the home country? | Discharge information, review requirements and contact channels |
CAR-T related treatment directions and procedures
Treatment direction: first distinguish the disease type, and then discuss the product
"Hematology cancer" is not a single disease. Even if the disease name is the same, the specific classification, past medications, target expression, and physical status may be different. The following table is for illustrating consultation directions and is not intended to be a list or indication sheet for all Jiahui’s current products.
| disease direction | Consultation focus | What needs to be clarified by the hospital |
|---|---|---|
| Lymphoma | Pathological subtype, previous treatment and recurrence history | Whether it is suitable for related cell therapy and whether additional pathology or examination is needed |
| multiple myeloma | Previous medications, transplant experience, and current disease status | Product conditions, follow-up evaluation and supportive care arrangements |
| leukemia | Specific type, previous treatments and test results | Whether it meets the requirements of the product or project being consulted |
| Specific solid tumor programs | Pathological type, related targets and previous treatments | Whether it is currently carried out, indications and conditions for admission |
Jiahui’s public information introduces CAR-T related services; patients should ask the hospital to explain the products and basis for use based on their own situation. Treatment data for different diseases and approval scopes in different countries cannot be directly interchanged.
Stage arrangement from assessment to follow-up
- 01condition assessmentConfirm diagnosis and treatment conditions
- 02Cell collectionCarry out according to hospital plan
- 03Prepare and waitAdditional treatment if necessary
- 04Preparation and returnComplete in-hospital medical arrangements
- 05Observation and follow-upMonitor response and schedule review
Safety monitoring is part of treatment
CAR-T may cause adverse reactions such as CRS, neurological toxicity, and infection, and some cases may be serious. Before receiving treatment, you should understand the hospital’s monitoring arrangements, risk management and post-discharge contact information. The course of recovery in case reports does not predict the outcome in another patient.
American Cancer Society · Treatment and Adverse Effects ↗When making your itinerary, confirm three times separately
- Time of first arrival:The preliminary information communication is different from the confirmed appointment, and the hospital admission arrangement should be obtained.
- Treatment phase time:Ask about the hospitalization or arrangements in Shanghai required during cell preparation and before and after reinfusion.
- Return time:It is up to the doctor to judge based on recovery and review needs, and treatment should not be concluded with a fixed number of days commitment.
Hematology Oncology and Cell Therapy Doctor
The following three doctors can be inquired on the Jiahui official website. The introduction is based on public professional resumes. The specific consultation time and scope of consultation must be confirmed with the hospital.
Hao Siguo
Director of Hematology Department·Chief Physician/Professor
According to Jiahui’s official website, Professor Hao Siguo is also the director of the Hematology Department of Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine. He has studied hematopoietic stem cell transplantation in Singapore and conducted tumor immunotherapy research in Canada.
Professional direction:Leukemia, lymphoma, multiple myeloma and complex blood diseases; CAR-T cell therapy and hematopoietic stem cell transplantation.
Understand the direction of blood tumors and cell therapy. Specific admissions and treatment options must be confirmed by the hospital.
View doctor’s official profile ↗
Xu Rong
Medical Oncologist·Hematology Oncology
Graduated from Shanghai Jiao Tong University School of Medicine with a master's degree in hematology. He worked at Shanghai First People's Hospital and was engaged in clinical work in the hematopoietic stem cell transplantation ward.
Professional direction:Autologous and allogeneic hematopoietic stem cell transplantation, CAR-T therapy for relapsed and refractory hematological tumors, and management of transplant complications such as infection.
The official website lists Mandarin and English. Use the name "Xu Rong" on the hospital's current Chinese page.
View doctor’s official profile ↗
Xuan Linli
Jiahui International Cancer Center · Director of Medical Oncology
He has clinical training background in China and the United States. He received specialist training in medical oncology and hematology in the United States and was engaged in clinical oncology treatment.
Professional direction:Diagnosis and treatment of solid tumors and hematological tumors, cancer risk assessment, post-CAR-T infusion management, symptom control and palliative care.
The official website lists the programs in Mandarin and English, and introduces the relevant specialty certification background of the American Board of Internal Medicine.
View doctor’s official profile ↗Public treatment records of international patients
The following are case summaries reported publicly by Jiahui, not Zoying customer reviews. The reported disease background and stage results will be retained, and unpublished long-term efficacy will not be added.
Open cases
Each source
Sorted by reporting time
Not used as a comparison of efficacy
Foreign lymphoma patient was discharged after completing reinfusion
Jiahui reported that a foreign lymphoma patient received CAR-T treatment in 2023, completed T cell collection in July, reinfusion in August, and was discharged from hospital in September. The report recorded the process of transferring from a dedicated ward to a general ward, and subsequent monitoring and follow-up are still required.
Jiahui Official Case Report ↗Received cell therapy after multiple lines of treatment
Jiahui released in January 2024 that a foreign myeloma patient diagnosed in 2008 underwent drug treatment and two autologous transplants, and was treated again due to recurrence. The report recorded that he was discharged from the hospital about two weeks after the CAR-T infusion, and introduced the support of multi-specialty collaboration.
Published by Jiahui · PR Newswire ↗Treatment report of a 78-year-old New Zealand patient
The November 2025 news released by Jiahui introduced the situation of a 78-year-old New Zealand patient with relapsed myeloma receiving CAR-T treatment. The focus for elderly cases is individual assessment and supportive care, which cannot be used to determine that all patients of the same age are suitable for treatment.
Published by Jiahui · PR Newswire ↗Muhammad’s cross-border lymphoma treatment
In May 2026, Jiahui reported that 36-year-old Muhammad had previously received chemotherapy and transplantation. He received CAR-T related treatment after coming to Shanghai. The report recorded the short-term lesion changes, pain improvement, and review plan after returning to China. It also introduced language communication support.
Jiahui Official Case Report ↗When reading cases, pay attention to this information
Look first to see if the diagnosis is similar to your own, and then look at previous treatments, observation times, and actual reported results. A single case can describe a diagnosis and treatment experience, but cannot answer the individual success rate. If you want to learn more, ask the treating doctor to explain evidence similar to your condition, rather than just comparing news headlines.
Quality, certification and professional background
JCI certification and hospital information
The official website of Jiahui Campus introduces its JCI certification. Certification can serve as a clue to the quality and safety system; it is not a guarantee of the efficacy of a particular treatment, nor is it equivalent to a Class IIIA rating for a Chinese hospital.
Jiahui Official · Hospital certification information ↗Look at different levels of qualifications separately
| Information level | What can be confirmed on this page | Patients need further confirmation |
|---|---|---|
| Hospital quality | Hospital official website introduces JCI certification situation | Current certificate scope and validity status |
| Professional team | Official resumes and professional directions of three doctors | Actual patients staff and consultation arrangements |
| Institutional cooperation | The official website of the cancer center introduces the cooperation background of Massachusetts General Hospital | Whether overseas consultations are involved |
| Specific treatments | The hospital publicly introduces CAR-T related diagnosis and treatment | Proposed products, conditions and individual plans |
| Service relations | Zoying organizes public information and provides non-medical coordination | Specific service scope and matters confirmed by both parties |
The honor display should have clear sources
The official website of the hospital also introduced the experience of medical security and other aspects of the China International Import Expo. This article provides verification through the original data portal and does not produce unconfirmed medals, rankings or "Best Hospital" labels. When formally choosing a hospital, honorary background and the needs of this specialty should be considered separately.
Shanghai as a medical destination
Medical Services and Urban Facilities
Shanghai’s open international medical development policy involves specialized specialist services, public hospital international medical departments and the facilitation of international patient services. For this topic, a more practical starting point is to find a reception team suitable for the condition and confirm the medical arrangements and stay requirements one by one.
Shanghai Municipal Government·Implementation Opinions on International Medical Innovation Development ↗Shanghai International Service Portal provides English guides on transportation, payment and life services. Patients and family members can read the corresponding information first, and then choose accommodation and travel methods based on the treatment location. Life arrangements during medical treatment should be subject to the medical plan, and avoid putting travel schedule before treatment and observation.
Shanghai International Service Portal ↗Hospital location and travel preparations
Jiahui International Hospital is located at No. 689 Guiping Road, Xuhui District, Shanghai. After confirming the appointment, you can use the hospital's official transportation guide to check the hospital entrance and route; you should communicate with the doctor in advance whether long-distance travel is suitable for your current physical condition.
Jiahui Official Transportation Guide ↗Patient Information
Confirm the medical record list, document language and submission channel, and retain the examination date and complete report.
Language Communication
Indicate the main language of the patient and accompanying family members, and confirm arrangements for translation and written instructions.
Stay in Shanghai
First clarify the plan for hospital arrival and review, and then confirm accommodation, transportation and accompanying arrangements.
Contact after leaving the hospital
Confirm the re-examination items, medication instructions, and the hospital contact method after returning to your home country.
Visa and accommodation are confirmed separately
The hospital admission reply, visa application and accommodation reservation are different matters. Entry requirements should be verified with official channels based on nationality, purpose of travel and planned length of stay, and the hospital should confirm whether the required medical documents can be provided. Medical advice or appointment records do not automatically translate into visa approval.
FAQs for International Patients
01Which cancers can be consulted for CAR-T?
This topic focuses on the direction of blood tumors, including some lymphomas, multiple myeloma and leukemia. The name of the disease itself is not enough to determine whether it can be treated. The hospital also needs to check the specific type, target, previous treatment and indications of the product to be used. Solid tumor projects should be confirmed individually, and the treatment experience for one tumor cannot be applied to all cancers.
02What does it mean to partner with Massachusetts General Hospital?
The official website of Jiahui International Cancer Center introduces its strategic partnership with Massachusetts General Hospital and Cancer Center in the United States. If patients need overseas expert opinions, they should further inquire whether the diagnosis and treatment includes relevant services, participating doctors and written results; it cannot be determined that each treatment is approved by an overseas hospital based solely on the name of the cooperation.
03How to judge whether you are suitable?
The admissions team first reads past medical records and then determines the need for additional examinations and evaluations. It is recommended to ask the doctor clearly: whether it meets the conditions for the product to be used, whether there are other options, what the main risks are, and the next steps if CAR-T is not suitable.
04How long does the entire treatment take?
Treatment involves evaluation, cell collection and preparation, reinfusion and observation, and cannot be calculated based on the day of reinfusion alone. Different products, conditions and hospitalization procedures will affect scheduling. You should obtain a stage plan from the hospital to confirm the expected arrival time in Shanghai, whether hospitalization is required during the preparation period, and the review requirements after discharge, and then book your return trip.
05Does CAR-T have serious side effects?
Cytokine release syndrome (CRS), nervous system toxicity, infection, and cytopenia may occur, which require monitoring and treatment by a professional team. Patients should understand the risk information before treatment, contact channels in case of abnormalities, and precautions after discharge. Mild reactions in cases should not be interpreted as risks for one's own treatment.
06Can international patients consult Jiahui?
The Jiahui official website has an international patient service entrance and an international patient contact email. Whether specific diseases will be accepted, how to submit information, available time and service content are subject to the hospital's reply. Disclosure of cases can demonstrate the presence of international patients and does not constitute a guarantee of current appointments or admissions.
07Is communication provided in English or other languages?
The official websites of the three doctors introduced on this page are listed in Mandarin and English. Translation forms in other languages, whether they are provided on-site and corresponding arrangements need to be confirmed in advance. The initial communication can indicate the patient's primary language and ask in which language the written treatment plan, informed consent, and discharge materials are available.
08How to connect cell preparation and hospital treatment?
Cell collection, product preparation and release, and hospital transfusion are different links. During consultation, the hospital can be asked to explain the product to be used, corresponding indications, preparation cycle and quality handover process. Do not interpret the hospital's CAR-T diagnosis and treatment as the hospital's own production of all cell products.
09What medical records should be provided for the first evaluation?
Prepare diagnostic and pathology reports, past treatment history, recent examinations, current medications and allergy history as required by the hospital. You can ask whether bone marrow examination, molecular testing and original imaging files are required. Request a list of information and secure submission channels before providing personal medical information; avoid sending just screenshots or reports with missing dates.
10How to get started with Zoying?
You can first explain the known diagnosis, the direction you want to consult, the main communication language and the planned time. Zoying provides information consultation and non-medical coordination within the agreed scope; the hospital is responsible for diagnosis, treatment plans and medical judgment. The consultation portal of the local test environment only demonstrates the process, and the submission will not be actually sent.
ZOYINGHEALTH / PATIENT COORDINATION
Start with specialist needs and understand the arrangements for medical treatment in Shanghai
Zoying Medical can communicate around hospital information, document preparation and non-medical services within the agreed scope. Admission, examination and treatment are determined by hospital assessment.
Understand the consultation process Return to hospital information →Information and display instructions
This page is a local internal display draft. The text is written independently. The column organization refers to the format of the hospital's special page. Hospital and doctor information is based on Jiahui official information; medical science information refers to NCI and the American Cancer Society. Foreign information does not serve as the basis for indications of Chinese products. Photos are displayed through the hospital's public address, and the rights to the photos belong to the original rights holders. Use authorization must be confirmed before official release. The introduction of public information does not mean that Zoying has obtained authorization from Jiahui Hospital or doctors.
The current consultation form is a demonstration and will not be actually sent. Data verification date: October 4, 2026.